| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/24/2001 | CN1281430A N-alkanoylphenylalanine derivatives |
| 01/24/2001 | CN1281362A Novel combination medicine |
| 01/24/2001 | CN1061042C Adhesion receptor antagonists |
| 01/24/2001 | CN1061041C Piperidine derivatives |
| 01/24/2001 | CN1061037C 取代的1－芳基吡唑 Substituted 1-aryl-pyrazole |
| 01/24/2001 | CN1061036C Substituted pyrazolyl benzenesulfonamides for treating inflammation |
| 01/23/2001 | USRE37029 Antipsychotic and analgesic agents |
| 01/23/2001 | US6177562 Chelated complexes of paramagnetic metals with low toxicity |
| 01/23/2001 | US6177491 Block oligomers containing 1-Hydrocarbyloxy-2,2,6,6-Tetramethyl-4-piperidyl groups as stabilizers for organic materials |
| 01/23/2001 | US6177473 Factor x inhibitor |
| 01/23/2001 | US6177459 Substituted heterocyclic compounds and their use as fungicides |
| 01/23/2001 | US6177455 Administering a nitrogen-containing heterocyclic compound |
| 01/23/2001 | US6177432 Farnesyltransferase inhibiting quinazolinones |
| 01/23/2001 | US6177429 Dihydropyrazine derivatives as NPY antagonists |
| 01/23/2001 | US6177428 Treatment of sexual dysfunction; stimulation of endogenous nitrogen monoxide synthesis |
| 01/23/2001 | US6177423 N-(hydroxy or protected hydroxy)-benzo(de)isoquinoline-1,3-dione derivatives; bacterial dna gyrase and dna topoisomerase inhibitors useful for antibacterial agents having reduced drug resistance and reduced side effects |
| 01/23/2001 | CA2196885C Carboxamide compounds (changed to n-(2-(pyrrolidinyl-1)-1-phenylethyl) acetamides as kappa receptor antagonists) |
| 01/23/2001 | CA2022451C Anti-psychotic piperidynl benzimidazole compounds |
| 01/23/2001 | CA2021340C Cyclic vinylogous n-hydroxy-n-methylureas useful as 5-lipoxygenase inhibitors |
| 01/21/2001 | CA2314373A1 Heteroaryl-substituted pyrrole derivatives, their preparation and their thereapeutic uses |
| 01/18/2001 | WO2001004119A1 Amido spiropiperidines promote the release of growth hormone |
| 01/18/2001 | WO2001004116A2 Neurotrophic pyrrolidines and piperidines, and related compositions containing them |
| 01/18/2001 | WO2001004115A2 Novel process for synthesis of heteroaryl-substituted urea compounds |
| 01/18/2001 | WO2001004110A1 Benzimidazole compounds |
| 01/18/2001 | WO2001004109A1 Process for the production of 2-(2-pyridinylmethylsulphinyl)-1h-benzimidazoles |
| 01/18/2001 | WO2001004107A1 SUBSTITUTED α,β-ANELLATED BUTYROLACTONES |
| 01/18/2001 | WO2001004102A1 Quinazoline derivatives |
| 01/18/2001 | WO2001004091A1 Neurotrophic 2-azetidinecarboxylic acid derivatives, and related compositions and methods |
| 01/18/2001 | WO2001004090A2 Neurotrophic tetrahydroisoquinolines and tetrahydrothienopyridines, and related compositions and methods |
| 01/18/2001 | WO2000071516A3 INHIBITORS OF FACTOR Xa |
| 01/18/2001 | WO2000059285A3 NOVEL LACTAM INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE |
| 01/18/2001 | WO2000035492A3 Vitronectin receptor antagonist pharmaceuticals |
| 01/18/2001 | WO1999064049A9 Novel antibacterial agents |
| 01/18/2001 | CA2379149A1 Neurotrophic pyrrolidines and piperidines, and related compositions and methods |
| 01/18/2001 | CA2378291A1 Quinazoline derivatives |
| 01/17/2001 | EP1069124A1 2-Benzimidazolylamine compounds as ORL1-receptor agonists |
| 01/17/2001 | EP1069110A1 Sulfonamide derivatives |
| 01/17/2001 | EP1068224A2 Pharmaceuticals for the imaging of angiogenic disorders |
| 01/17/2001 | EP1068202A1 1-(3-heteroarylpropyl- or -prop-2-enyl)-4-benzylpiperidines used as nmda receptor antagonists |
| 01/17/2001 | EP1068198A1 5-heteroaryl substituted indoles |
| 01/17/2001 | EP1068197A1 Substituted piperidines, method for their preparation and their use as pesticides and fungicides |
| 01/17/2001 | EP1068196A1 Nitrate salt of anti-ulcer medicine |
| 01/17/2001 | EP1068194A1 Pde iv inhibiting pyridine derivatives |
| 01/17/2001 | EP1068193A1 Benzylpiperazinyl- and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine d 4? receptor antagonists |
| 01/17/2001 | EP1068189A1 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinthione derivatives, their preparation and their use as hiv reverse transcriptase inhibitors |
| 01/17/2001 | EP1068187A1 Pyrazole inhibitors of cytokine production |
| 01/17/2001 | EP1068185A1 Compounds with activity on muscarinic receptors |
| 01/17/2001 | EP1067926A2 Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus or cyclosporins |
| 01/17/2001 | EP1067917A2 Method of treating dopaminergic and gaba-nergic disorders |
| 01/17/2001 | EP1067894A2 Protease inhibitors |
| 01/17/2001 | EP0983258A4 N-hydroxy 4-sulfonyl butanamide compounds |
| 01/17/2001 | EP0977740A4 Methods for synthesizing 2-substituted imidazoles |
| 01/17/2001 | EP0721944B1 Imidazolidine derivative and use thereof |
| 01/17/2001 | EP0716654B1 Substituted lactic-acid derivatives with an azido-group in the beta position, their preparation and their use as herbicides and antidotes |
| 01/17/2001 | CN1280576A Morpholino end-capped, hindered amine substituted aminotriazine and their use as light stabilizers |
| 01/17/2001 | CN1280569A 1,2-dihydro-2-oxoquinoline derivatives |
| 01/17/2001 | CN1280568A Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 01/17/2001 | CN1280566A Method of synthesis of pyrrole amides |
| 01/17/2001 | CN1280126A Substituted pyrazolyl benzene sulfone amides compounds for curing inflammation |
| 01/17/2001 | CN1280125A Substituted pyrazolyl benzene sulfone amides compounds for curing inflammation |
| 01/16/2001 | US6175013 1-(2-methoxybenzyl)-2-((4-phenyl-1-piperazinyl)methyl)-4-(1h -indol-3-ylmethyl)-2-imidazoline, for example; adminstering to treat anxiety, depression, psychosis, and schizophrenia |
| 01/16/2001 | US6175012 Processes and intermediates for the preparation of piperazine derivatives |
| 01/16/2001 | US6174915 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
| 01/16/2001 | US6174907 Therapy and prophylaxis of hyperlipemia or arterial sclerosis; as additive of a silver halide photosensitive material, liquid crystal material |
| 01/16/2001 | US6174905 As carcinostatic agent to a hematologic malignancy and a solid carcinoma |
| 01/16/2001 | US6174901 For treatment of rheumatoid arthritis, pagets disease, osteophorosis, multiple myeloma, uveititis, acute or chronic myelogenous leukemia, pancreatic .beta. cell destruction, osteoarthritis, rheumatoid spondylitis, gouty arthritis etc. |
| 01/16/2001 | US6174900 Substituted piperidine derivative for treating urinary disturbance |
| 01/16/2001 | US6174898 Method of treating filariae |
| 01/16/2001 | US6174889 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 01/16/2001 | US6174883 3-substituted-2-oxindoles derivatives |
| 01/16/2001 | CA2314008A1 2-benzimidazolylamine compounds as orl1-receptor agonists |
| 01/16/2001 | CA2025932C Pyrazole-3-carboxamides |
| 01/16/2001 | CA2021954C Substituted triazolinones, triazolinethiones and triazolinimines as angiotensin ii antagonists |
| 01/16/2001 | CA2010800C Protein labelling |
| 01/11/2001 | WO2001002391A2 Bicyclic aromatic compounds for treating drug addiction |
| 01/11/2001 | WO2001002390A1 Quinolinecarboxylic acid derivative or salts thereof |
| 01/11/2001 | WO2001002389A1 Crystals of benzimidazole compounds |
| 01/11/2001 | WO2001002388A1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 01/11/2001 | WO2001002387A1 N-imidazolylmethyl carboxamides as nitric oxide production inhibitors |
| 01/11/2001 | WO2001002386A1 SELECTIVE M2 MUSCARINIC RECEPTOR ANTAGONISTS HAVING 5H-DIBENZ[b,f]AZEPINE STRUCTURE |
| 01/11/2001 | WO2001002385A1 1-(quinolin-4-yl)-1h-pyrazole derivatives and their use as fungicides |
| 01/11/2001 | WO2001002381A1 Piperazine derivatives as modulators of chemokine receptor activity |
| 01/11/2001 | WO2001002376A1 Amino-alkyl derivatives |
| 01/11/2001 | WO2001002373A1 Dihydrobenzodiazepins and their use for treating dyslipidemia |
| 01/11/2001 | WO2001002369A2 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 01/11/2001 | WO2001002368A1 N-heterocyclic derivatives with neuronal activity |
| 01/11/2001 | WO2001002358A2 Cyclized amide derivatives for treating or preventing neuronal damage |
| 01/11/2001 | WO2001002356A1 Indoline or tetrahydroquinoline derivatives |
| 01/11/2001 | WO2001002345A2 Mono and multifunctional alkoxyamines for the preparation of functionalized macromers |
| 01/11/2001 | WO2001001988A1 Compounds having cytokine inhibitory activity |
| 01/11/2001 | WO2001001986A1 Method of reducing neuronal injury or apoptosis |
| 01/11/2001 | WO2001001972A2 SELECTIVE iGluR5 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF MIGRAINE |
| 01/11/2001 | WO2000061608A3 Low-molecular inhibitors of complement proteases |
| 01/11/2001 | WO2000059904A3 Compounds and methods to treat cardiac failure and other disorders |
| 01/11/2001 | WO2000054729A3 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 01/11/2001 | WO2000053596A3 Imidazole compounds as histamine h3 ligands |
| 01/11/2001 | DE19920360A1 Light-stable electrochromic system for e.g. windows, protective glasses or car mirrors contains an electrochromic medium and a yellow filter with an absorption peak of specified wavelength |
| 01/11/2001 | CA2378389A1 Therapeutic agents |
| 01/11/2001 | CA2376657A1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 01/11/2001 | CA2375806A1 Mono and multifunctional alkoxyamines for the preparation of functionalized macromers |